| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 11.191 | 24.951 | 36.709 | 24.220 | 32.267 | 26.509 |
| Total Income - EUR | - | - | - | - | 11.191 | 24.951 | 36.709 | 24.220 | 32.434 | 26.861 |
| Total Expenses - EUR | - | - | - | - | 2.541 | 9.663 | 8.135 | 9.435 | 10.677 | 18.871 |
| Gross Profit/Loss - EUR | - | - | - | - | 8.649 | 15.288 | 28.574 | 14.785 | 21.757 | 7.990 |
| Net Profit/Loss - EUR | - | - | - | - | 8.538 | 15.048 | 28.209 | 14.542 | 21.479 | 6.903 |
| Employees | - | - | - | - | 1 | 2 | 1 | 1 | 1 | 2 |
Check the financial reports for the company - Topendodontics S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 609 | 528 | 449 | 383 | 314 | 0 |
| Current Assets | - | - | - | - | 17.187 | 33.770 | 56.911 | 73.526 | 30.553 | 28.625 |
| Inventories | - | - | - | - | 0 | 467 | 457 | 458 | 0 | 0 |
| Receivables | - | - | - | - | 0 | 6.179 | 6.552 | 6.572 | 1.187 | 568 |
| Cash | - | - | - | - | 17.187 | 27.123 | 49.903 | 66.496 | 29.366 | 28.057 |
| Shareholders Funds | - | - | - | - | 8.580 | 23.465 | 51.153 | -3.510 | 17.980 | 24.782 |
| Social Capital | - | - | - | - | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | 9.216 | 10.834 | 6.208 | 77.419 | 12.888 | 3.842 |
| Income in Advance | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8623 - 8623" | |||||||||
| CAEN Financial Year |
8623
|
|||||||||
Comments - Topendodontics S.r.l.